Sandoz Group AG
OTC: SDZNY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Richard Saynor
- Employees
- 22,049
- Headquarters
- Rotkreuz, Switzerland
- IPO year
- 2023
- Market cap
- $36.5B
- Website
- https://www.sandoz.com
Loading SDZNY…
Loading profile data…Frequently asked questions about SDZNY
What does Sandoz Group AG (SDZNY) do?
Sandoz Group AG operates as a global pharmaceutical enterprise, primarily focusing on the development, manufacturing, and commercialization of generic medicines and biosimilars. Their offerings include finished dosage forms of small molecule pharmaceuticals, often supplied to other businesses. Additionally, the company provides protein-based and...
Where does SDZNY trade?
Sandoz Group AG (SDZNY) trades on the Other OTC.
What sector is SDZNY in?
Sandoz Group AG (SDZNY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sandoz Group AG?
Richard Saynor is the chief executive officer of Sandoz Group AG (SDZNY).
Where is Sandoz Group AG headquartered?
Sandoz Group AG is headquartered in Switzerland.
Does SDZNY pay a dividend?
Yes — Sandoz Group AG (SDZNY) paid a trailing twelve-month dividend of USD 1.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SDZNY go public?
Sandoz Group AG (SDZNY) completed its initial public offering in 2023.
Is SDZNY an ADR?
Yes — SDZNY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Sandoz Group AG reporting and dividends follow the underlying issuer.